Nerve growth factor (NGF)-mediated protection of neural crest cells from antimitotic agent-induced apoptosis: The role of the low-affinity NGF receptor

Journal of Neuroscience

Volumn 16, Issue 12, 1996, Pages 3895-3899

  Cortazzo, Megan H ^a   Kassis, Edmund S ^a   Sproul, Kari A ^a   Schor, Nina Felice ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

apoptosis; neuroblastoma; NGF; NGF receptors; p75; trkA

Indexed keywords

NERVE GROWTH FACTOR; ZINOSTATIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL PROTECTION; GENE EXPRESSION; HUMAN; HUMAN CELL; MITOSIS; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR BINDING; SITE DIRECTED MUTAGENESIS;

EID: 0029886779     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.16-12-03895.1996     Document Type: Article

References (42)

1. Azar C, Scavarda NJ, Reynolds CP, Brodeur CM (1991) Multiple defects of the nerve growth factor receptor in human neuroblastomas. Prog Clin Biol Res 366:219-226.
2. Barbacid M (1993) Nerve growth factor: a tale of two receptors. Oncogene 8:2033-2042.
3. LNTR reduces NGF binding to trkA on PC12 cells. Neuron 13:203-215.
4. Blatt J, Gula MJ, Orlando SJ, Finn LS, Misra DN, Dickman PS (1995) Indolent course of advanced neuroblastoma in children older than 6 years at diagnosis. Cancer 76:890-894.
5. Brach MA, de Vos S, Gruss HJ, Herrmann F (1992) Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death. Blood 80:2920-2924.
6. Bredesen D (1995) Neural apoptosis. Ann Neurol 38:839-851.
7. NGFR)-associated protein kinase activity. Soc Neurosci Abstr 21:808.
8. Collins MK, Perkins GR, Rodriguez-Tarduchy G, Nieto MA, Lopez-Rivas A (1994) Growth factors as survival factors: regulation of apoptosis. Bioessays 16:133-138.
9. Cordon-Cardo C, Tapley P, Jung S, Nanduri V, O'Rourke E, Lamballe F, Kovary K, Klein R, Jones KR, Reichardt LF, Barbacid M (1991) The trk tyrosine protein kinase mediates the mitogenic properties of nerve growth factor and neurotrophin-3. Cell 66:173-183.
10. Cortazzo M, Nylander KD, Schor NF (1995) NGF-mediated resistance of neuroblastoma to chemotherapeutic-induced apoptosis: the role of the low-affinity receptor. Ann Neurol 38:517.
11. Cotman CW, Anderson AJ (1995) A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol Neurobiol 10:19-45.
12. Cotter TG, Lennon SV, Glynn JG, Martin SJ (1990) Cell death via apoptosis and its relationship to growth, development, and differentiation of both tumour and normal cells. Anticancer Res 10:1153-1160.
13. Couldwell WT, Hinton DR, He S, Chen TC, Sebat I, Weiss MH, Law RE (1994) Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines. FEBS Lett 345:43-46.
14. Evans AE, D'Angio GJ, Randolph J (1991) A proposed staging for children with neuroblastoma: Children's Cancer Study Group A. Cancer 27:374-378.
15. Falcione M, Milligan KD, Schwartz MC, Schor NF (1993) Prevention of neocarzinostatin-induced cell death and morphologic change in SKN-SH human neuroblastoma cells by continuous exposure to nerve growth factor. Biochem Pharmacol 46:731-738.
16. Greene LA, Kaplan DR (1995) Early events in neurotrophin signalling via Trk and p75 receptors. Curr Opin Neurobiol 5:579-587.
17. Harrington EA, Bennett MR, Fanidi A, Evan GI (1994) c-Myc-induced apoptosis in flbroblasts is inhibited by specific cytokines. EMBO J 13:3286-3295.
18. Hartsell TL, Yalowich JC, Ritke M, Martinez AJ, Schor NF (1995) Induction of apoptosis in murine and human neuroblastoma cell lines by the enediyne natural product neocarzinostatin. J Pharmacol Exp Ther 275:479-485.
19. Hartsell TL, Hinman LM, Hamann PR, Schor NF (1996) Determinants of the response of neuroblastoma cells to DNA damage: the roles of pretreatment cell morphology and chemical nature of the damage. J Pharmacol Exp Ther, in press.
20. Hempstead BL, Martin-Zanca D, Kaplan DR, Parada LF, Chao MV (1991) High-affinity NGF binding requires co-expression of the trk protooncogene and the low affinity NGF receptor. Nature 350:678-683.
21. Huber LJ, Chao MV (1995) A potential interaction of p75 and trkA NGF receptors revealed by affinity crosslinking and immunoprecipitation. J Neurosci Res 40:557-563.
22. Ibanez CF, Ebendal T, Barbany G, Murray-Rust J, Blundell TL, Persson H (1992) Disruption of the low affinity receptor-binding site in NGF allows neuronal survival and differentiation by binding to the trk gene product. Cell 69:329-341.
23. Ishizaki Y, Burne JF, Raff MC (1994) Autocrine signals enable chondrocytes to survive in culture. J Cell Biol 126:1069-1077.
24. Kaplan DR, Hempstead BL, Martin-Zanca D, Chao MV, Parada LF (1991) The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science 252:554-558.
25. Kremer NE, D'Arcangelo GD, Thomas SM, DeMarco M, Brugge JS (1991) Signal transduction by nerve growth factor and fibroblast growth factor in PC12 cells requires a sequence of src and ras actions. J Cell Biol 115:809-819.
26. Lucarelli E, Kaplan DR, Thiele CJ (1995) Selective regulation of TrkA and TrkB receptors by retinoic acid and interferon-7 in human neuroblastoma cell lines. J Biol Chem 270:24725-24731.
27. Martin SJ, Green DR (1994) Apoptosis as a goal of cancer therapy. Curr Opin Oncol 6:616-621.
28. TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells. Cancer Res 55:1798-1806.
29. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM (1993) Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 328:847-854.
30. Nakagawara A, Azar CG, Scavarda NJ, Brodeur GM (1994) Expression and function of TrkB and BDNF in human neuroblastomas. Mol Cell Biol 14:759-767.
31. Ohmichi M, Decker SJ, Pang L, Saltiel AR (1991) Nerve growth factor binds to the 140 kd trk proto-oncogene product and stimulates its association with the src homology domain of phospholipase C-γ1. Biochem Biophys Res Commun 179:217-223.
32. Prichard J, Hickman JA (1994) Why does stage 4S neuroblastoma regress spontaneously? Lancet 344:869-870.
33. Rabizadeh S, Oh J, Zhong L-t Yang J, Bitler CM, Butcher LL, Bredesen DE (1993) Induction of apoptosis by the low-affinity NGF receptor. Science 261:345-348.
34. Raff MC (1992) Social controls on cell survival and cell death. Nature 356:397-400.
35. Saltiel AR, Ohmichi M (1993) Pleiotropic signaling from receptor tyrosine kinases. Curr Opin Neurobiol 3:352-359.
36. Shin A, Laramee GR, Schmelzer CH, Burton LE, Winslow JW (1994) Mutagenesis identifies amino-terminal residues of nerve growth factor necessary for trk receptor binding and biological activity. J Biol Chem 269:27679-27686.
37. Tilly JL, Billig H, Kowalski KI, Hsueh AJ (1992) Epidermal growth factor and basic fibroblast growth factor suppress the spontaneous onset of apoptosis in cultured rat ovarian granulosa cells and follicles by a tyrosine kinase-dependent mechanism. Mol Endocrinol 6:1942-1950.
38. LNGFR regulates Trk signal transduction and NGF-induced neuronal differentiation in MAH cells. Neuron 12:733-745.
39. Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y, Fontana A (1994) Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J Clin Invest 94:954-964.
40. Wolf DE, McKinnon CA, Daou M-C, Stephens RM, Kaplan DR, Ross AH (1995) Interaction with trkA immobilizes gp75 in the high affinity nerve growth factor receptor complex. J Biol Chem 270:2133-2138.
41. Wyllie AH (1992) Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Rev 11:95-103.
42. Yamashiro DJ, Nakagawara A, Ikegaki N, Liu XG, Brodeur GM (1996) Expression of TrkC in favorable human neuroblastomas. Oncogene 12:37-41.